{"id":"https://openalex.org/W7213239709","doi":"https://doi.org/10.63475/yjm.v5i2.0472","title":"Cholangiocarcinoma in 2026: Pathophysiology, Diagnostic Advances, and Evolving Therapeutic Landscape\u2014A Narrative Review","display_name":"Cholangiocarcinoma in 2026: Pathophysiology, Diagnostic Advances, and Evolving Therapeutic Landscape\u2014A Narrative Review","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7213239709","doi":"https://doi.org/10.63475/yjm.v5i2.0472"},"language":"en","primary_location":{"id":"doi:10.63475/yjm.v5i2.0472","doi":"https://doi.org/10.63475/yjm.v5i2.0472","is_oa":true,"landing_page_url":"https://doi.org/10.63475/yjm.v5i2.0472","pdf_url":"https://doi.org/10.63475/yjm.v5i2.0472","source":{"id":"https://openalex.org/S4387284869","display_name":"Yemen Journal of Medicine","issn_l":"2583-4614","issn":["2583-4614"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yemen Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.63475/yjm.v5i2.0472","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047145743","display_name":"Elmukhtar M. Habas","orcid":"https://orcid.org/0000-0002-7754-8993","observed_orcids":["https://orcid.org/0000-0002-7754-8993"]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]},{"id":"https://openalex.org/I4210103132","display_name":"Hamad General Hospital","ror":"https://ror.org/01bgafn72","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210103132"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["LY","QA"],"is_corresponding":false,"raw_author_name":"Elmukhtar Habas","raw_affiliation_strings":["Professor, Senior Consultant , Department of Medicine , Hamad General Hospital , Doha , Qatar","Radiology Resident , Tripoli Children Hospital , University of Tripoli , Tripoli , Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor, Senior Consultant , Department of Medicine , Hamad General Hospital , Doha , Qatar","institution_ids":["https://openalex.org/I4210103132","https://openalex.org/I49828101"]},{"raw_affiliation_string":"Radiology Resident , Tripoli Children Hospital , University of Tripoli , Tripoli , Libya","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091803482","display_name":"Aml Habas","orcid":"https://orcid.org/0009-0000-1862-2711","observed_orcids":["https://orcid.org/0009-0000-1862-2711"]},"institutions":[{"id":"https://openalex.org/I4210154678","display_name":"Libya Open University","ror":"https://ror.org/002a29y03","country_code":"LY","type":"education","lineage":["https://openalex.org/I4210154678"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Aml Habas","raw_affiliation_strings":["Medicine Resident , TCH , Open Libyan University , Tripoli , Libya","Specialist Hematology , Open Libyan University , Tripoli , Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Resident , TCH , Open Libyan University , Tripoli , Libya","institution_ids":["https://openalex.org/I4210154678"]},{"raw_affiliation_string":"Specialist Hematology , Open Libyan University , Tripoli , Libya","institution_ids":["https://openalex.org/I4210154678"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113790417","display_name":"Amnna Rayani","orcid":"https://orcid.org/0009-0005-5161-6555","observed_orcids":["https://orcid.org/0009-0005-5161-6555"]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Amnna Ali Rayani","raw_affiliation_strings":["Professor, Senior Consultant , University of Tripoli , Tripoli , Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor, Senior Consultant , University of Tripoli , Tripoli , Libya","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075285786","display_name":"Ala M Habas","orcid":"https://orcid.org/0009-0003-6488-8133","observed_orcids":["https://orcid.org/0009-0003-6488-8133"]},"institutions":[{"id":"https://openalex.org/I4210154678","display_name":"Libya Open University","ror":"https://ror.org/002a29y03","country_code":"LY","type":"education","lineage":["https://openalex.org/I4210154678"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Ala Habas","raw_affiliation_strings":["Medicine Resident , TCH , Open Libyan University , Tripoli , Libya","Specialist Hematology , Open Libyan University , Tripoli , Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Resident , TCH , Open Libyan University , Tripoli , Libya","institution_ids":["https://openalex.org/I4210154678"]},{"raw_affiliation_string":"Specialist Hematology , Open Libyan University , Tripoli , Libya","institution_ids":["https://openalex.org/I4210154678"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036131838","display_name":"Eshrak Habas","orcid":"https://orcid.org/0009-0004-1044-7110","observed_orcids":["https://orcid.org/0009-0004-1044-7110"]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]},{"id":"https://openalex.org/I4210103132","display_name":"Hamad General Hospital","ror":"https://ror.org/01bgafn72","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210103132"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["LY","QA"],"is_corresponding":false,"raw_author_name":"Eshrak Habas","raw_affiliation_strings":["Professor, Senior Consultant , Department of Medicine , Hamad General Hospital , Doha , Qatar","Radiology Resident , Tripoli Children Hospital , University of Tripoli , Tripoli , Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professor, Senior Consultant , Department of Medicine , Hamad General Hospital , Doha , Qatar","institution_ids":["https://openalex.org/I4210103132","https://openalex.org/I49828101"]},{"raw_affiliation_string":"Radiology Resident , Tripoli Children Hospital , University of Tripoli , Tripoli , Libya","institution_ids":["https://openalex.org/I23906160"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.54210836,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"05","issue":"02","first_page":"355","last_page":"364"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/intrahepatic-cholangiocarcinoma","display_name":"intrahepatic cholangiocarcinoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hilar-cholangiocarcinoma","display_name":"hilar cholangiocarcinoma","score":0.9900000095367432},{"id":"https://openalex.org/keywords/distal-cholangiocarcinoma","display_name":"distal cholangiocarcinoma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/fgfr2-fusion","display_name":"FGFR2 fusion","score":0.8629999756813049},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.9950000047683716},{"id":"https://openalex.org/keywords/fgfr2-inhibitor","display_name":"FGFR2 inhibitor","score":0.6779999732971191},{"id":"https://openalex.org/keywords/pemigatinib","display_name":"pemigatinib","score":0.8450000286102295},{"id":"https://openalex.org/keywords/futibatinib","display_name":"futibatinib","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ivosidenib","display_name":"ivosidenib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/zanidatamab","display_name":"zanidatamab","score":0.996999979019165},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/first-line-systemic-therapy","display_name":"first-line systemic therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/delayed-diagnosis","display_name":"delayed diagnosis","score":0.777999997138977},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.9760000109672546},{"id":"https://openalex.org/keywords/molecular-classification","display_name":"molecular classification","score":0.7269999980926514},{"id":"https://openalex.org/keywords/access-to-cancer-therapy","display_name":"access to cancer therapy","score":0.45399999618530273},{"id":"https://openalex.org/keywords/health-equity","display_name":"health equity","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8616999983787537},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.5618000030517578},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5285000205039978},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.45500001311302185},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4357999861240387},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42590001225471497},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41100001335144043},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.37619999051094055},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3517000079154968},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3407000005245209},{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.33239999413490295},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.32899999618530273},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.3248000144958496},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3203999996185303},{"id":"https://openalex.org/C2909135397","wikidata":"https://www.wikidata.org/wiki/Q124292","display_name":"Intrahepatic Cholangiocarcinoma","level":2,"score":0.31940001249313354},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.29510000348091125},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2937000095844269},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.2777999937534332},{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.273499995470047},{"id":"https://openalex.org/C2780416959","wikidata":"https://www.wikidata.org/wiki/Q22907415","display_name":"Companion diagnostic","level":3,"score":0.2685999870300293},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.26179999113082886},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.2556000053882599},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.25369998812675476}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.63475/yjm.v5i2.0472","doi":"https://doi.org/10.63475/yjm.v5i2.0472","is_oa":true,"landing_page_url":"https://doi.org/10.63475/yjm.v5i2.0472","pdf_url":"https://doi.org/10.63475/yjm.v5i2.0472","source":{"id":"https://openalex.org/S4387284869","display_name":"Yemen Journal of Medicine","issn_l":"2583-4614","issn":["2583-4614"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yemen Journal of Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.63475/yjm.v5i2.0472","doi":"https://doi.org/10.63475/yjm.v5i2.0472","is_oa":true,"landing_page_url":"https://doi.org/10.63475/yjm.v5i2.0472","pdf_url":"https://doi.org/10.63475/yjm.v5i2.0472","source":{"id":"https://openalex.org/S4387284869","display_name":"Yemen Journal of Medicine","issn_l":"2583-4614","issn":["2583-4614"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yemen Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213239709.pdf","grobid_xml":"https://content.openalex.org/works/W7213239709.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1661550176","https://openalex.org/W1942118595","https://openalex.org/W1970368087","https://openalex.org/W1992149176","https://openalex.org/W2008716434","https://openalex.org/W2038265408","https://openalex.org/W2091582111","https://openalex.org/W2115261608","https://openalex.org/W2134423861","https://openalex.org/W2140885919","https://openalex.org/W2188884265","https://openalex.org/W2467932635","https://openalex.org/W2594589478","https://openalex.org/W2720657558","https://openalex.org/W2808382000","https://openalex.org/W2942656542","https://openalex.org/W2948012423","https://openalex.org/W3007448808","https://openalex.org/W3010944770","https://openalex.org/W3024247862","https://openalex.org/W3083538896","https://openalex.org/W3115645837","https://openalex.org/W3145664714","https://openalex.org/W3173323135","https://openalex.org/W4212962821","https://openalex.org/W4291392344","https://openalex.org/W4309710859","https://openalex.org/W4365998338","https://openalex.org/W4379114671","https://openalex.org/W4387141633","https://openalex.org/W4387529402","https://openalex.org/W4402452564","https://openalex.org/W4402893211","https://openalex.org/W4410384052","https://openalex.org/W4417196302","https://openalex.org/W7163058381"],"related_works":["https://openalex.org/W4414333794","https://openalex.org/W4413345543","https://openalex.org/W2604648767","https://openalex.org/W6929901011","https://openalex.org/W7223124376","https://openalex.org/W2590986233","https://openalex.org/W3173813779","https://openalex.org/W7128008885","https://openalex.org/W4414741139","https://openalex.org/W2052001271"],"abstract_inverted_index":{"Cholangiocarcinoma":[0],"(CCA)":[1],"is":[2],"a":[3],"heterogeneous":[4],"malignancy":[5],"of":[6,33,120,156],"the":[7,118,126,138,153,174,221,226],"biliary":[8],"epithelium,":[9],"classified":[10],"into":[11,213],"intrahepatic,":[12],"perihilar,":[13],"and":[14,24,37,49,51,70,80,100,109,128,131,159,165,170,178,185,195,210],"distal":[15],"subtypes":[16],"with":[17,62,97,117],"distinct":[18,169],"molecular":[19,192,209],"signatures,":[20],"risk":[21,39],"factor":[22,65,84],"profiles,":[23],"clinical":[25,41],"behavior.":[26],"This":[27,204],"narrative":[28],"review":[29,205],"synthesizes":[30],"current":[31],"understanding":[32],"CCA":[34,182],"pathophysiology,":[35],"established":[36,124],"emerging":[38],"factors,":[40],"presentation,":[42],"diagnostic":[43,147,176],"modalities,":[44],"persistent":[45],"gaps":[46],"in":[47,77,91,142,162],"diagnosis":[48],"treatment,":[50],"recent":[52],"therapeutic":[53,211],"advances":[54],"through":[55,125],"mid-2026.":[56],"Molecular":[57],"classification":[58],"has":[59,114],"matured":[60],"substantially,":[61],"fibroblast":[63],"growth":[64,83],"receptor":[66,85],"2":[67,86],"(FGFR2)":[68],"fusions":[69],"isocitrate":[71],"dehydrogenase":[72],"1":[73],"(IDH1)":[74],"mutations":[75],"enriched":[76],"intrahepatic":[78,157],"disease":[79,158],"human":[81],"epidermal":[82],"(HER2)":[87],"amplification":[88],"more":[89],"common":[90],"extrahepatic":[92],"subtypes,":[93],"each":[94],"now":[95],"targetable":[96],"U.S.":[98],"Food":[99],"Drug":[101],"Administration":[102],"(FDA)-approved":[103],"agents,":[104],"including":[105],"pemigatinib,":[106],"futibatinib,":[107],"ivosidenib,":[108],"zanidatamab.":[110],"Firstline":[111],"systemic":[112],"therapy":[113],"shifted":[115],"meaningfully":[116],"incorporation":[119],"immune":[121],"checkpoint":[122],"inhibition,":[123],"TOPAZ-1":[127],"KEYNOTE-966":[129],"trials,":[130],"investigational":[132],"firstline":[133],"FGFR2":[134],"inhibition":[135],"data":[136],"from":[137],"FIGHT-302":[139],"trial":[140],"presented":[141],"2026.":[143],"Despite":[144],"these":[145],"advances,":[146],"delay":[148],"remains":[149,220],"common,":[150],"driven":[151],"by":[152],"nonspecific":[154],"presentation":[155],"technical":[160],"limitations":[161],"tissue":[163],"confirmation":[164],"serum":[166],"biomarkers.":[167],"A":[168],"underexplored":[171],"gap":[172],"concerns":[173],"epidemiology,":[175],"access,":[177],"treatment":[179],"availability":[180],"for":[181],"across":[183,216],"Arab":[184],"African":[186],"populations,":[187],"where":[188],"regional":[189],"incidence":[190],"data,":[191],"testing":[193],"infrastructure,":[194],"equitable":[196,214],"access":[197],"to":[198],"newly":[199],"approved":[200],"therapies":[201],"remain":[202],"limited.":[203],"argues":[206],"that":[207],"translating":[208],"precision":[212],"outcomes":[215],"all":[217],"affected":[218],"populations":[219],"central":[222],"unmet":[223],"task":[224],"facing":[225],"field.":[227]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-16T00:00:00"}